CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-16 | Alenson Carman Principal Accounting Officer | Option exercise · Restricted stock units | −790 | 0 | ||
| 2021-02-16 | Schenkein David P Director | Option exercise | +8,125 | 113,178 | ||
| 2021-02-16 | Schenkein David P Director | Shares withheld for taxes | −2,540 | 110,638 | ||
| 2021-02-16 | Schenkein David P Director | Option exercise · Restricted stock units | −8,125 | 0 | ||
| 2021-02-14 | Miles Darrin Chief Commercial Officer | Option exercise | +8,666 | 14,541 | ||
| 2021-02-14 | Miles Darrin Chief Commercial Officer | Option exercise · Restricted stock units | −8,666 | 17,334 | ||
| 2021-02-14 | Bowden Christopher Chief Medical Officer | Option exercise | +4,000 | 12,381 | ||
| 2021-02-14 | Bowden Christopher Chief Medical Officer | Option exercise · Restricted stock units | −4,000 | 8,000 | ||
| 2021-02-14 | FOUSE JACQUALYN A Chief Executive Officer | Option exercise | +11,333 | 61,761 | ||
| 2021-02-14 | FOUSE JACQUALYN A Chief Executive Officer | Shares withheld for taxes | −3,398 | 58,363 | ||
| 2021-02-14 | FOUSE JACQUALYN A Chief Executive Officer | Option exercise · Restricted stock units | −11,333 | 22,667 | ||
| 2021-02-14 | Alenson Carman Principal Accounting Officer | Option exercise | +889 | 1,073 | ||
| 2021-02-14 | Alenson Carman Principal Accounting Officer | Option exercise · Restricted stock units | −889 | 1,777 | ||
| 2021-02-10 | Miles Darrin Chief Commercial Officer | Grant or award · Restricted stock units | +11,000 | 11,000 | ||
| 2021-02-10 | Miles Darrin Chief Commercial Officer | Grant or award · Common stock | +44,000 | 44,000 | ||
| 2021-02-10 | FOUSE JACQUALYN A Chief Executive Officer | Grant or award · Stock option (right to buy) | +163,000 | 163,000 | ||
| 2021-02-10 | Car Bruce Chief Scientific Officer | Grant or award · Restricted stock units | +11,000 | 11,000 | ||
| 2021-02-10 | Car Bruce Chief Scientific Officer | Grant or award · Stock option (right to buy) | +44,000 | 44,000 | ||
| 2021-02-10 | Bowden Christopher Chief Medical Officer | Grant or award · Restricted stock units | +11,000 | 11,000 | ||
| 2021-02-10 | Bowden Christopher Chief Medical Officer | Grant or award · Stock option (right to buy) | +44,000 | 44,000 |
Page 44 of 48 · 941 trades